GLP-1

What Are GLP-1 Receptor Agonists and How Do They Work?

What Are GLP-1 Receptor Agonists and How Do They Work?

GLP-1 receptor agonists are a class of peptide-based medications that mimic glucagon-like peptide-1 (GLP-1), a hormone naturally produced in the gut after eating. They were first developed for type 2 diabetes but have become central to modern weight management, cardiovascular medicine, and metabolic health. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro,

Peptides for Weight Loss: What Actually Works

Peptides for Weight Loss: What Actually Works

Several classes of therapeutic peptides are studied for weight management, and they work through very different mechanisms. GLP-1 receptor agonists like semaglutide and tirzepatide target hunger signaling and metabolic regulation. Growth hormone secretagogues like ipamorelin and CJC-1295 influence body composition by promoting lean mass and fat metabolism. And peptides like

What the Ozempic Halo Effect Means for Peptide Therapy

What the Ozempic Halo Effect Means for Peptide Therapy

Semaglutide generated $29.3 billion in global revenue in 2024. It has been featured on the cover of Time magazine, debated in Congress, and discussed in conversations that have nothing to do with diabetes. Along the way, it did something unexpected: it made the word "peptide" a cultural

Tirzepatide vs Semaglutide: Comparing GLP-1 Peptides for Weight Loss

Tirzepatide vs Semaglutide: Comparing GLP-1 Peptides for Weight Loss

Tirzepatide and semaglutide are the two most prescribed medications for weight management and type 2 diabetes in 2026, and they're both peptides. Patients frequently ask which is better, which is safer, and which is right for them. The honest answer requires understanding how they differ mechanistically, what the